Online Evaluation of the Diagnostic Accuracy of BlinkLab's Digital Assessments for Autism
NCT07590973
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This observational study aims to evaluate how patterns of behavioral and sensorimotor responses measured using the BlinkLab Dx1 smartphone application relate to autism diagnoses in children ages 2 to 11. BlinkLab Dx1 is a non-invasive, smartphone-based application under development as a diagnostic aid for healthcare providers assessing autism. In this study, children who have undergone a neurodevelopmental assessment within the past 12 months will complete two short, video-based sessions using the BlinkLab Dx1 app.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Autism
- Autism Spectrum Disorder
- Autism Spectrum Disorder (ASD)
- Neurodevelopmental Conditions
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 2 to 11 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Blinklab Limited
- Last updated on ClinicalTrials.gov
- May 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New Jersey · 1
- Remote study conducted nationwide; all participation occurs via smartphone app at home. · Princeton, NJ
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.